Home Biochemical predictors of metabolically unhealthy obesity in children and adolescents
Article
Licensed
Unlicensed Requires Authentication

Biochemical predictors of metabolically unhealthy obesity in children and adolescents

  • Ah Young Cho , Jung Gi Roh , Young Suk Shim , Hae Sang Lee EMAIL logo and Jin Soon Hwang
Published/Copyright: November 22, 2021

Abstract

Background

Children and adolescents with obesity can now be classified according to metabolic profile, as those with metabolically healthy obesity (MHO) and those with metabolically unhealthy obesity (MUO). We aimed to determine the prevalence of MUO and identify its biochemical predictors in pediatric patients with obesity.

Methods

We evaluated the medical records of 187 boys and girls with obesity. The children were divided into MHO and MUO groups, and anthropometric and biochemical parameters were assessed. Oral glucose tolerance test (OGTT) was used to identify impaired glucose regulation and hyperinsulinism, and binary logistic regression analysis was used to determine predictors of MUO in children with obesity.

Results

Of the 187 children, MUO was found in 71.7% (n=134) and MHO in 28.3% (n=53); those in the MHO group were younger than those in the MUO group. Blood pressure, triglyceride, total cholesterol, and uric acid levels were significantly higher in the MUO group than in the MHO group. Further, the MUO group exhibited a significantly higher level of insulin resistance (p<0.05) than the MHO group. Serum levels of uric acid and homeostasis model assessment of insulin resistance index (HOMA-IR) were confirmed as biochemical predictors of the MUO phenotype in children with obesity.

Conclusions

The ratio of MUO in children with obesity was relatively high; further, serum levels of uric acid and HOMA-IR can be used as biochemical predictors of MUO.


Corresponding author: Hae Sang Lee, Department of Pediatrics, Ajou University School of Medicine, San 5, Wonchon-dong, Yeongtong-gu, Suwon 443-721, Korea, Tel: +82 31 219 4454, Fax: +82 31 219 5169, E-mail:
Ah Young Cho and Jung Gi Roh contributed equally to this work.
  1. Funding: None declared.

  2. Author contributions: Study concept and design (AYC, HSL); data collection (JGR, HSL); analysis and interpretation of data (AYC, YSS, HSL, JSW); drafting of the manuscript (AYC, HSL); critical revision of the manuscript (HSL, JSH); supervision (HSL).

  3. Competing interests: No potential conflict of interest relevant to this article was reported.

  4. Informed consent: The need for informed consent was waived due to the retrospective nature of the study design.

  5. Ethics approval: This study was approved by the Institutional Review Board of Ajou University Hospital (AJIRB-MED-MDB-19-538). The need for informed consent was waived due to the retrospective nature of the study design; all measurements were performed as part of routine practice. The study adhered to the tenets of the Declaration of Helsinki.

  6. Data availability statement: All relevant data are included in the paper and its Supporting In-formation files. Otherwise, the raw data analyzed during the current study are not publicly available as the owners have given their written consent only to use the data for the current study after IRB approval. The datasets used and/or analyzed in the present study are available from the corresponding author on reasonable request.

References

1. Reilly, JJ, Kelly, J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes 2011;35:891–8. https://doi.org/10.1038/ijo.2010.222.Search in Google Scholar PubMed

2. Wang, Y, Lobstein, T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes 2006;1:11–25. https://doi.org/10.1080/17477160600586747.Search in Google Scholar PubMed

3. Yanovski, JA. Pediatric obesity. Rev Endocr Metab Disord 2001;2:371–83. https://doi.org/10.1016/s0031-3955(05)70356-4.Search in Google Scholar PubMed

4. Oh, K, Jang, M, Lee, N, Moon, J, Lee, C, Yoo, M. Prevalence and trends in obesity among Korean children and adolescents in 1997 and 2005. Korean J Pediatr 2008;51:950–5. https://doi.org/10.3345/kjp.2008.51.9.950.Search in Google Scholar

5. Bussler, S, Penke, M, Flemming, G, Elhassan, YS, Kratzsch, J, Sergeyev, E, et al.. Novel insights in the metabolic syndrome in childhood and adolescence. Horm Res Paediatr 2017;88:181–93. https://doi.org/10.1159/000479510.Search in Google Scholar PubMed

6. Franks, PW, Hanson, RL, Knowler, WC, Sievers, ML, Bennett, PH, Looker, HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010;362:485–93. https://doi.org/10.1056/nejmoa0904130.Search in Google Scholar

7. Navarro, E, Funtikova, AN, Fíto, M, Schröder, H. Can metabolically healthy obesity be explained by diet, genetics, and inflammation? Mol Nutr Food Res 2015;59:75–93. https://doi.org/10.1002/mnfr.201400521.Search in Google Scholar PubMed

8. Blüher, S, Schwarz, P. Metabolically healthy obesity from childhood to adulthood – does weight status alone matter? Metabolism 2014;63:1084–92. https://doi.org/10.1016/j.metabol.2014.06.009.Search in Google Scholar PubMed

9. Genovesi, S, Antolini, L, Orlando, A, Gilardini, L, Bertoli, S, Giussani, M, et al.. Cardiovascular risk factors associated with the metabolically healthy obese (MHO) phenotype compared to the metabolically unhealthy obese (MUO) phenotype in children. Front Endocrinol 2020;11:27. https://doi.org/10.3389/fendo.2020.00027.Search in Google Scholar PubMed PubMed Central

10. Damanhoury, S, Newton, AS, Rashid, M, Hartling, L, Byrne, JLS, Ball, GDC. Defining metabolically healthy obesity in children: a scoping review. Obes Rev 2018;19:1476–91. https://doi.org/10.1111/obr.12721.Search in Google Scholar PubMed

11. Prince, RL, Kuk, JL, Ambler, KA, Dhaliwal, J, Ball, GD. Predictors of metabolically healthy obesity in children. Diabetes Care 2014;37:1462–8. https://doi.org/10.2337/dc13-1697.Search in Google Scholar PubMed

12. Hinnouho, GM, Czernichow, S, Dugravot, A, Nabi, H, Brunner, EJ, Kivimaki, M, et al.. Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study. Eur Heart J 2015;36:551–9. https://doi.org/10.1093/eurheartj/ehu123.Search in Google Scholar PubMed PubMed Central

13. Barlow, SE, Dietz, WH. Obesity evaluation and treatment: expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services. Pediatrics 1998;102:E29. https://doi.org/10.1542/peds.102.3.e29.Search in Google Scholar PubMed

14. Moon, JS, Lee, SY, Nam, CM, Choi, JM, Choe, BK, Seo, JW, et al.. Korean National Growth Charts: review of developmental process and an outlook. Korean J Pediatr 20072008;51:1–25.10.3345/kjp.2008.51.1.1Search in Google Scholar

15. Lee, C, Moon, J, Choi, J, Nam, C, Lee, S, Oh, K, et al.. Normative blood pressure references for Korean children and adolescents. Korean J Pediatr 2008;51:33–41. https://doi.org/10.3345/kjp.2008.51.1.33.Search in Google Scholar

16. Tanner, JM, Whitehouse, RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170–9. https://doi.org/10.1136/adc.51.3.170.Search in Google Scholar PubMed PubMed Central

17. Valerio, G, Licenziati, MR, Iannuzzi, A, Franzese, A, Siani, P, Riccardi, G, et al.. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006;16:279–84. https://doi.org/10.1016/j.numecd.2005.12.007.Search in Google Scholar PubMed

18. Pratley, RE, Weyer, C. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 2001;44:929–45. https://doi.org/10.1007/s001250100580.Search in Google Scholar PubMed

19. El-Koofy, N, El-Karaksy, H, El-Akel, W, Helmy, H, Anwar, G, El-Sayed, R, et al.. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children. Eur J Radiol 2012;81:3120–3. https://doi.org/10.1016/j.ejrad.2012.06.020.Search in Google Scholar PubMed

20. Siest, G, Schiele, F, Galteau, MM, Panek, E, Steinmetz, J, Fagnani, F, et al.. Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem 1975;21:1077–87. https://doi.org/10.1093/clinchem/21.8.1077.Search in Google Scholar

21. Evia-Viscarra, ML, Guardado-Mendoza, R. Comparison between metabolically healthy obesity and metabolically unhealthy obesity by different definitions among Mexican children. J Pediatr Endocrinol Metab 2020;33:215–22. https://doi.org/10.1515/jpem-2019-0077.Search in Google Scholar PubMed

22. Rocha, E, Vogel, M, Stanik, J, Pietzner, D, Willenberg, A, Körner, A, et al.. Serum uric acid levels as an indicator for metabolically unhealthy obesity in children and adolescents. Horm Res Paediatr 2018;90:19–27. https://doi.org/10.1159/000490113.Search in Google Scholar PubMed

23. Vukovic, R, Milenkovic, T, Mitrovic, K, Todorovic, S, Plavsic, L, Vukovic, A, et al.. Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents. Eur J Pediatr 2015;174:1649–55. https://doi.org/10.1007/s00431-015-2587-4.Search in Google Scholar PubMed

24. Margolis-Gil, M, Yackobovitz-Gavan, M, Phillip, M, Shalitin, S. Which predictors differentiate between obese children and adolescents with cardiometabolic complications and those with metabolically healthy obesity? Pediatr Diabetes 2018;19:1147–55. https://doi.org/10.1111/pedi.12694.Search in Google Scholar PubMed

25. Corica, D, Aversa, T, Valenzise, M, Messina, MF, Alibrandi, A, De Luca, F, et al.. Does family history of obesity, cardiovascular, and metabolic diseases influence onset and severity of childhood obesity? Front Endocrinol 2018;9:187. https://doi.org/10.3389/fendo.2018.00187.Search in Google Scholar PubMed PubMed Central

26. Reilly, JJ, Armstrong, J, Dorosty, AR, Emmett, PM, Ness, A, Rogers, I, et al.. Early life risk factors for obesity in childhood: cohort study. BMJ 2005;330:1357. https://doi.org/10.1136/bmj.38470.670903.e0.Search in Google Scholar

27. Vukovic, R, Dos Santos, TJ, Ybarra, M, Atar, M. Children with metabolically healthy obesity: a review. Front Endocrinol 2019;10:865. https://doi.org/10.3389/fendo.2019.00865.Search in Google Scholar PubMed PubMed Central

28. Corica, D, Oreto, L, Pepe, G, Calabrò, MP, Longobardo, L, Morabito, L, et al.. Precocious preclinical cardiovascular sonographic markers in metabolically healthy and unhealthy childhood obesity. Front Endocrinol 2020;11:56. https://doi.org/10.3389/fendo.2020.00056.Search in Google Scholar PubMed PubMed Central

29. Caprio, S, Santoro, N, Weiss, R. Childhood obesity and the associated rise in cardiometabolic complications. Nat Metab 2020;2:223–32. https://doi.org/10.1038/s42255-020-0183-z.Search in Google Scholar PubMed PubMed Central

30. Levy-Marchal, C, Arslanian, S, Cutfield, W, Sinaiko, A, Druet, C, Marcovecchio, ML, et al.. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab 2010;95:5189–98. https://doi.org/10.1210/jc.2010-1047.Search in Google Scholar PubMed PubMed Central

31. Gustafsson, D, Unwin, R. The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol 2013;14:164. https://doi.org/10.1186/1471-2369-14-164.Search in Google Scholar PubMed PubMed Central

32. Juárez-López, C, Klünder-Klünder, M, Medina-Bravo, P, Madrigal-Azcárate, A, Mass-Díaz, E, Flores-Huerta, S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Publ Health 2010;10:318. https://doi.org/10.1186/1471-2458-10-318.Search in Google Scholar PubMed PubMed Central

33. Moulin-Mares, SRA, Oliosa, PR, Faria, ER, Zago-Gomes, MP, Mill, JG. Association of uric acid with cardiovascular risk in Brazilian children and adolescents. Nutr Metab Cardiovasc Dis 2021;31:314–21. https://doi.org/10.1016/j.numecd.2020.09.012.Search in Google Scholar PubMed

34. Bo, S, Cavallo-Perin, P, Gentile, L, Repetti, E, Pagano, G. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 2001;31:318–21. https://doi.org/10.1046/j.1365-2362.2001.00812.x.Search in Google Scholar PubMed

Received: 2021-08-18
Accepted: 2021-11-02
Published Online: 2021-11-22
Published in Print: 2022-01-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review Article
  3. Medullary thyroid carcinoma in children: current state of the art and future perspectives
  4. Original Articles
  5. Newly defined peroxisomal disease with novel ACBD5 mutation
  6. Pediatric adrenocortical tumors cohort characteristics and long-term follow-up at a single Argentinian tertiary center
  7. Sleep disorder and behavior problems in children with type 1 diabetes mellitus
  8. Increased hepcidin levels and non-alcoholic fatty liver disease in obese prepubertal children: a further piece to the complex puzzle of metabolic derangements
  9. Screening for testicular adrenal rest tumors among children with congenital adrenal hyperplasia at King Fahad Medical City, Saudi Arabia
  10. The association between vitamin D levels and metabolic syndrome components among metropolitan adolescent population
  11. Utility of wrist circumference in recognition of metabolic syndrome in overweight and obese South Indian children and adolescents
  12. Ketoacidosis in new-onset type 1 diabetes: did the severity increase during the COVID-19 pandemic?
  13. Predictors of decreased bone mineral density in childhood systemic lupus erythematosus: possible role of osteoprotegerin gene polymorphisms
  14. Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study
  15. Biochemical predictors of metabolically unhealthy obesity in children and adolescents
  16. Adiposity rebound in very-low-birth-weight infants
  17. The association between a metabolically healthy overweight/obesity phenotype and markers of inflammation among Chinese children and adolescents aged 10–18 years
  18. Case Reports
  19. Management of perinatal HPP during critical illness/ECMO
  20. Wolfram-like syndrome – another face of a rare disease in children
  21. Two Japanese siblings with arginase-1 deficiency identified using a novel frameshift mutation of ARG1 (p.Lys41Thrfs2)
  22. An atypical presentation of a pathogenic STK11 gene variant in siblings not fulfilling the clinical diagnostic criteria for Peutz-Jeghers Syndrome
Downloaded on 18.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0542/html
Scroll to top button